Independent of Calorie Intake, Short-term Alternate-day Fasting Alleviates NASH, With Modulation of Markers of Lipogenesis, Autophagy, Apoptosis, and Inflammation in Rats

Eicosapentaenoic and docosahexaenoic acids attenuate methotrexate-induced apoptosis and suppression of splenic T, B-Lymphocytes and macrophages with modulation of expression of CD3, CD20 and CD68

(2021) Hassan Reda Hassan Elsayed et al.   TISSUE & CELL

Lipophagy Impairment Is Associated With Disease Progression in NAFLD

(2020) Simone Carotti et al.   Frontiers in Physiology

Can Dasatinib Ameliorate the Hepatic changes, Induced by Long Term Western Diet, in Mice?

(2020) Hassan Reda Hassan Elsayed et al.   ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER

A histomorphometric study on the hepatoprotective effects of a green rooibos extract in a diet-induced obese rat model

(2019) J.I. Layman et al.   ACTA HISTOCHEMICA

The Dualistic Effect of COX-2-Mediated Signaling in Obesity and Insulin Resistance

(2019) Pei-Chi Chan et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum

(2019) Xing-Xin Yang et al.   BIOMEDICINE & PHARMACOTHERAPY

Is the hepatocyte ultrastructural zonal heterogeneity changed by overnight (16 h) fasting? Morphometric study

(2019) Hassan Reda Hassan Elsayed et al.   ULTRASTRUCTURAL PATHOLOGY

Chicory ( Cichorium intybus L.) polysaccharides attenuate high-fat diet induced non-alcoholic fatty liver disease via AMPK activation

(2018) Yulong Wu et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Insights into the Role of PPARβ/δ in NAFLD

(2018) Jiapeng Chen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease

(2018) Claus Uhrenholt Christensen et al.   PLoS One

Apoptosis and non-alcoholic fatty liver diseases

(2018) Tatsuo Kanda et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague–Dawley rats

(2018) Victoria Svop Jensen et al.   Diabetology & Metabolic Syndrome

Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis

(2018) Begoña Porteiro et al.   Molecular Metabolism

Hepatoprotective effect of bisbenzylisoquinoline alkaloid tiliamosine from Tiliacora racemosa in high-fat diet/diethylnitrosamine-induced non-alcoholic steatohepatitis

(2018) S. Sylvester Darvin et al.   BIOMEDICINE & PHARMACOTHERAPY

A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease

(2018) Josephine Skat-Rørdam et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease

(2018) Zhibin Yan et al.   LIFE SCIENCES

Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

(2018) Zobair M. Younossi et al.   TRANSPLANTATION

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

(2016) Vlad Ratziu et al.   GASTROENTEROLOGY

Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease

(2016) Yaron Rotman et al.   GUT

Alternate-day fasting protects the livers of mice against high-fat diet–induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling

(2016) Wanwei Yang et al.   NUTRITION RESEARCH

Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease

(2015) Michal Pawlak et al.   JOURNAL OF HEPATOLOGY

Differential adaptive responses to 1- or 2-day fasting in various mouse tissues revealed by quantitative PCR analysis

(2015) Junya Yamamoto et al.   FEBS Open Bio

Fasting: Molecular Mechanisms and Clinical Applications

(2014) Valter D. Longo et al.   Cell Metabolism

Effect of Diet on Expression of Genes Involved in Lipid Metabolism, Oxidative Stress, and Inflammation in Mouse Liver–Insights into Mechanisms of Hepatic Steatosis

(2014) Helen J. Renaud et al.   PLoS One

Peroxisome Proliferator-Activated Receptor α Activation Induces Hepatic Steatosis, Suggesting an Adverse Effect

(2014) Fang Yan et al.   PLoS One

Experimental models of non-alcoholic fatty liver disease in rats

(2014) Otto Kucera   WORLD JOURNAL OF GASTROENTEROLOGY

Fasting of mice: a review

(2013) TL Jensen et al.   LABORATORY ANIMALS

Fiji: an open-source platform for biological-image analysis

(2012) Johannes Schindelin et al.   NATURE METHODS

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

Regulation of lipid metabolism by p53 – fighting two villains with one sword

(2012) Ido Goldstein et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Attenuation of Reperfusion-Induced Hepatocyte Apoptosis is Associated with Reversed bcl-2/bax Ratio in Hemi-Hepatic Artery-Preserved Portal Occlusion

(2011) Shan Jin et al.   JOURNAL OF SURGICAL RESEARCH

Reactive oxygen species, cellular redox systems, and apoptosis

(2010) Magdalena L. Circu et al.   FREE RADICAL BIOLOGY AND MEDICINE

A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet

(2010) Julio C. Fraulob et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity

(2010) Roger H. Unger et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

N-3 polyunsaturated fatty acid regulation of hepatic gene transcription

(2008) Donald B Jump   CURRENT OPINION IN LIPIDOLOGY

A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease

(2008) C. Fernández-Miranda et al.   DIGESTIVE AND LIVER DISEASE